These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 30035186)
21. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163 [TBL] [Abstract][Full Text] [Related]
22. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population. Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients. Lv Z; Weng X; Du C; Zhang C; Xiao H; Cai X; Ye S; Cheng J; Ding C; Xie H; Zhou L; Wu J; Zheng S Mol Carcinog; 2016 May; 55(5):1024-33. PubMed ID: 26086159 [TBL] [Abstract][Full Text] [Related]
24. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells. Liu TP; Lo HL; Wei LS; Hsiao HH; Yang PM Anticancer Drugs; 2015 Feb; 26(2):139-47. PubMed ID: 25203626 [TBL] [Abstract][Full Text] [Related]
25. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Gao SB; Zheng QF; Xu B; Pan CB; Li KL; Zhao Y; Zheng QL; Lin X; Xue LX; Jin GH Mol Cancer Res; 2014 Oct; 12(10):1388-97. PubMed ID: 24916103 [TBL] [Abstract][Full Text] [Related]
26. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. Ma L; Chua MS; Andrisani O; So S World J Gastroenterol; 2014 Jan; 20(2):333-45. PubMed ID: 24574704 [TBL] [Abstract][Full Text] [Related]
27. Exploiting epigenetic vulnerabilities for cancer therapeutics. Mair B; Kubicek S; Nijman SM Trends Pharmacol Sci; 2014 Mar; 35(3):136-45. PubMed ID: 24529765 [TBL] [Abstract][Full Text] [Related]
28. Novel mechanism of attenuation of LPS-induced NF-κB activation by the heat shock protein 90 inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in human lung microvascular endothelial cells. Thangjam GS; Dimitropoulou C; Joshi AD; Barabutis N; Shaw MC; Kovalenkov Y; Wallace CM; Fulton DJ; Patel V; Catravas JD Am J Respir Cell Mol Biol; 2014 May; 50(5):942-52. PubMed ID: 24303801 [TBL] [Abstract][Full Text] [Related]
29. Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer. Zhao J; Lawless MW Cytokine; 2013 Dec; 64(3):626-37. PubMed ID: 24120848 [TBL] [Abstract][Full Text] [Related]
30. First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumors. Brunetto AT; Ang JE; Lal R; Olmos D; Molife LR; Kristeleit R; Parker A; Casamayor I; Olaleye M; Mais A; Hauns B; Strobel V; Hentsch B; de Bono JS Clin Cancer Res; 2013 Oct; 19(19):5494-504. PubMed ID: 24065624 [TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification. Liu C; Liu L; Shan J; Shen J; Xu Y; Zhang Q; Yang Z; Wu L; Xia F; Bie P; Cui Y; Zhang X; Bian X; Qian C Cancer Lett; 2013 Oct; 339(1):60-9. PubMed ID: 23879963 [TBL] [Abstract][Full Text] [Related]
32. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Bolden JE; Shi W; Jankowski K; Kan CY; Cluse L; Martin BP; MacKenzie KL; Smyth GK; Johnstone RW Cell Death Dis; 2013 Feb; 4(2):e519. PubMed ID: 23449455 [TBL] [Abstract][Full Text] [Related]
33. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062 [TBL] [Abstract][Full Text] [Related]
35. The SGBS cell strain as a model for the in vitro study of obesity and cancer. Allott EH; Oliver E; Lysaght J; Gray SG; Reynolds JV; Roche HM; Pidgeon GP Clin Transl Oncol; 2012 Oct; 14(10):774-82. PubMed ID: 22855155 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells. Kanno K; Kanno S; Nitta H; Uesugi N; Sugai T; Masuda T; Wakabayashi G; Maesawa C Oncol Rep; 2012 Sep; 28(3):867-73. PubMed ID: 22766642 [TBL] [Abstract][Full Text] [Related]
37. HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. Xie HJ; Noh JH; Kim JK; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Lee JY; Park H; Nam SW PLoS One; 2012; 7(4):e34265. PubMed ID: 22496786 [TBL] [Abstract][Full Text] [Related]
38. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893 [TBL] [Abstract][Full Text] [Related]
39. Multiple roles of class I HDACs in proliferation, differentiation, and development. Reichert N; Choukrallah MA; Matthias P Cell Mol Life Sci; 2012 Jul; 69(13):2173-87. PubMed ID: 22286122 [TBL] [Abstract][Full Text] [Related]
40. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Shen J; Wang S; Zhang YJ; Kappil M; Wu HC; Kibriya MG; Wang Q; Jasmine F; Ahsan H; Lee PH; Yu MW; Chen CJ; Santella RM Hepatology; 2012 Jun; 55(6):1799-808. PubMed ID: 22234943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]